Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 β-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan

Microbiology and Immunology

Volumn 56, Issue 7, 2012, Pages 480-485

  Harada, Kazuki ^a,b   Nakai, Yuka ^a   Kataoka, Yasushi ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Cats; Dogs; Escherichia coli; Extended spectrum lactamase

Indexed keywords

AMPICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE CMY 2; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA LACTAMASE CTX M 27; BETA LACTAMASE DHA 1; BETA LACTAMASE TEM 1; CEFAZOLIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; COTRIMOXAZOLE; DIHYDROSTREPTOMYCIN; ENROFLOXACIN; IMIPENEM; KANAMYCIN; OXYTETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLACMY 1 GENE; BLACMY 2 GENE; BLACTX M GENE; CAT; CTX M 27 BETA LACTAMASE GENE; DOG; ESCHERICHIA COLI; EXTRAINTESTINAL PATHOGENIC ESCHERICHIA COLI; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; SEROTYPING;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CAT DISEASES; CATS; CEPHALOSPORINS; DOG DISEASES; DOGS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; JAPAN; MOLECULAR SEQUENCE DATA; PHYLOGENY;

ANIMALIA; CANIS FAMILIARIS; ESCHERICHIA COLI;

EID: 84862859827     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2012.00463.x     Document Type: Article

References (37)

1. Beutin L. (1999) Escherichia coli as a pathogen in dogs and cats. Vet Res 30: 285-98.
2. Carattoli A., Lovari S., Franco A., Cordaro G., Di Matteo P., Battisti A. (2005) Extended-spectrum beta-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003. Antimicrob Agents Chemother 49: 833-5.
3. Ewers C., Grobbel M., Stamm I. (2010) Emergence of human pandemic O25: H4-ST131 CTX-M-15 extended-spectrum-beta-lactamase-producing Escherichia coli among companion animals. J Antimicrob Chemother 65: 651-60.
4. O'Keefe A., Hutton T.A., Schifferli D.M., Rankin S.C. (2010) First detection of CTX-M and SHV extended-spectrum β-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States. Antimicrob Agents Chemother 54: 3489-92.
5. Harada K., Niina A., Nakai Y., Kataoka Y., Takahashi T. (2012) Prevalence of antimicrobial resistance in relation to virulence genes and phylogenetic origins among urogenital Escherichia coli isolates from dogs and cats in Japan. Am J Vet Res 73: 409-17.
6. Pedersen K., Pedersen K., Jensen H., Finster K., Jensen V.F., Heuer O.E. (2007) Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs. J Antimicrobial Chemother 60: 775-81.
7. Féria C., Ferreira E., Correia J.D., Gonçalves J., Caniça M. (2002) Patterns and mechanisms of resistance to β-lactams and β-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal. J Antimicrob Chemother 49: 77-85.
8. Grobbel M., Lübke-Becker A., Alešík E., Schwarz S., Wallmann J., Werckenthin C., Wieler L.H. (2007) Antimicrobial susceptibility of Escherichia coli from swine, horses, dogs and cats as determined in the BfT-GermVet monitoring program 2004-2006. Berl Münch Tierärztl Wochenschr 120: 391-401.
9. Clinical and Laboratory Standards Institute. (2008) Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard - third edition. CLSI document M31-A3. Wayne, PA.
10. Clinical and Laboratory Standards Institute. (2010) Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20. Wayne, PA.
11. Kojima A., Ishii Y., Ishihara K., Esaki H., Asai T., Oda C., Tamura Y., Takahashi T., Yamaguchi K. (2005) Extended-spectrum-β-lactamse-producing Escherichia coli strains isolated from farm animals from 1999 to 2002: report from the Japanese Veterinary Antimicrobial Resistance Monitoring Program. Antimicrob Agents Chemother 49: 3533-7.
12. Pérez-Pérez F.J., Hanson N.D. (2002) Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40: 2153-62.
13. CTX-M genes by multiplex PCR assay. J Med Microbiol 54: 1183-7.
14. Mena A., Plasencia V., Garcia L., Hidalgo O., Avestarán J.I., Alberti S., Borrell N., Pérez J.L., Oliver A. (2006) Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development. J Clin Microbiol 44: 2831-7.
15. Clermont O., Lavollay M., Vimont S., Deschamps C., Forestier C., Branger C., Denamur E., Arlet G. (2008) The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61: 1024-8.
16. Centers for Disease Control and Prevention. (2004) One-day (24-48 h) standardization laboratory protocol for molecular sub-typing of Escherichia coli O157:H7, non-typhoidal Salmonella serotypes, and Shigella sonnei by pulsed-field gel electrophoresis (PFGE). In: PulseNet PFGE manual. National Center for Infectious Diseases, Atlanda, GA.
17. Hattori, T., Nakane K., Kawamura K. (2011) Multidrug-resistant phenotype and prevalence of CTX-M-27 in extended-spectrum β-lactamase-producing uropathogenic Escherichia coli. J Jpn Soc Clin Microbiol 21: 25-34. In Japanese. Abstract in English.
18. Peirano G., Richardson D., Nigrin J., McGeer A., Loo V., Toye B., Alfa M., Pienaar C., Kibsey P., Pitout JD. (2010) High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-β-lactamase-producing Escherichia coli isolates from Canada. Antimicrob Agents Chemother 54: 1327-30.
19. Romero E.D., Padilla T.P., Hernández A.H., Grande R.P., Vázquez M.F., García I.G., García-Rodríguez J.A., Muňoz Bellido J.L. (2007) Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamses. Diagn Microbiol Infect Dis 59: 433-7.
20. Song W., Lee H., Lee K., Jeong S.H., Bae I.K., Kim J.S. Kwak H.S. (2009) CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 58: 261-6.
21. Yu Y., Ji S., Chen Y., Zhou W., Wei Z., Li L., Ma Y. (2007) Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J Infect 54: 53-7.
22. CTX-M extended-spectrum β-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microbiol Infect 16: 1475-81.
23. Cantón R., Coque T.M. (2004) The CTX-M β-lactamase pandemic. Curr Opin Microbiol 9: 466-75.
24. Yamasaki K., Komatsu M., Abe N., Fukuda S., Miyamoto Y., Higuchi T., Ono T., Nishio H., Sueyoshi N., Kida K., Satoh K., Toyokawa M., Nishi I., Sakamoto M., Akagi M., Nakai I., Kofuku T., Orita T., Wada Y., Jikimoto T., Kinoshita S., Miyamoto K., Hirai I., Yamamoto Y. (2010) Laboratory surveillance for prospective plasmid-mediated AmpC β-lactamses in the Kinki region of Japan. J Clin Microbiol 48: 3267-73.
25. Rossolini G.M., D'Andrea M.M., Mugnaioli C. (2008) The spread of CTX-M-type extended-spectrum beta-lactamases. Clin Microbiol Infect 14 Suppl 1: 33-41.
26. Jacoby G.A. (2009) AmpC beta-lactamases. Clin Microbiol Rev 22:161-82.
27. Rogers B.A., Sidjabat H.E., Paterson D.L. (2011) Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 66: 1-14.
28. Pomba C., da Fonseca J.D., Baptista B.C., Correia J.D., Martínez-Martínez L. (2009) Detection of the pandemic O25-ST131 human virulent Escherichia coli CTX-M-15-producing clone harboring the qnrB2 and aac(6')-Ib-cr genes in a dog. Antimicrob Agents Chemother 53: 327-8.
29. Cortés P., Blanc V., Mora A., Dahbi G., Blanco J.E., Blanco M., López C., Andreu A., Navarro F., Alonso M.P., Bou G., Blanco J., Llagostera M. (2010) Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl Environ Microbiol 76: 2799-805.
30. Naseer U., Natås O.B., Haldorsen B.C., Bue B., Grundt H., Walsh T.R., Sundsfjord A. (2007) Nosocomial outbreak of CTX-M-15-producing E. coli in Norway. APMIS115: 120-6.
31. Mora A., Blanco M., López C., Mamani R., Blanco J.E., Alonso M.P., García-Garrote F., Dahbi G., Herrera A., Fernández A., Fernández B., Agulla A., Bou G., Blanco J. (2011) Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21, 42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. Int J Antimicrob Agents 37: 16-21.
32. Johnson J.R., Johnston B., Clabots C.R., Kuskowski M.A., Roberts E., DebRoy C. (2008) Virulence genotypes and phylogenetic background of Escherichia coli serogroup O6 isolates from humans, dogs, and cats. J Clin Microbiol 46: 417-22.
33. Moreno A., Bello H., Guggiana D., Domínquez M., González G. (2008) Extended-spectrum β-lactamases belonging to CTX-M group produced by Escherichia coli strains isolated from companion animals treated with enrofloxacin. Vet Microbiol 129: 203-8.
34. Lagacé-Wiens P.R., Nichol K.A., Nicolle L.E., Decorby M.R., McCracken M., Alfa M.J., Mulvey M.R., Zhanel G.G. (2007) ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in Manitoba. Can J Infect Dis Med Microbiol 18: 133-7.
35. Coque T.M., Baquero F., Canton R. (2008) Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill 13: 4.
36. Jørgensen R.L., Nielsen J.B., Friis-Møller A., Fjeldsøe-Nielsen H., Schønning K. (2010) Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotypes. J Antimicrob Chemother 65: 460-4.
37. Caroff N., Espaze E., Gautreau D., Richet H., Reynaud A. (2000) Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC. J Antimicrob Chemother 45: 783-8.